Connecting you to content on EBSCOhost

Works matching IS 22969403 AND DT 2021 AND VI 6 AND IP 3

Results: 6

1

Front & Back Matter.

Published in:: Inflammatory Intestinal Diseases, 2021, v. 6, n. 3, p. 1, doi. 10.1159/000519760
Publication type:: Article

2

Analysis of the Long-Term Prognosis in Japanese Patients with Ulcerative Colitis Treated with New Therapeutic Agents and the Correlation between Prognosis and Disease Susceptibility Loci.

Published in:

Inflammatory Intestinal Diseases, 2021, v. 6, n. 3, p. 154, doi. 10.1159/000518371

By:

Hishinuma, Kasumi;
Moroi, Rintaro;
Okamoto, Daisuke;
Shimoyama, Yusuke;
Kuroha, Masatake;
Shiga, Hisashi;
Kakuta, Yoichi;
Kinouchi, Yoshitaka;
Masamune, Atsushi

Publication type:

Article

3

A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis.

Published in:

Inflammatory Intestinal Diseases, 2021, v. 6, n. 3, p. 140, doi. 10.1159/000517474

By:

de Vallière, Cheryl;
Bäbler, Katharina;
Busenhart, Philipp;
Schwarzfischer, Marlene;
Maeyashiki, Chiaki;
Schuler, Cordelia;
Atrott, Kirstin;
Lang, Silvia;
Spalinger, Marianne R.;
Scharl, Michael;
Ruiz-Castro, Pedro A.;
Hausmann, Martin;
Rogler, Gerhard

Publication type:

Article

4

Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis.

Published in:

Inflammatory Intestinal Diseases, 2021, v. 6, n. 3, p. 123, doi. 10.1159/000518003

By:

Mosli, Mahmoud;
Alawadhi, Sameer;
Hasan, Fuad;
Abou Rached, Antoine;
Sanai, Faisal;
Danese, Silvio

Publication type:

Article

5

Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results.

Published in:

Inflammatory Intestinal Diseases, 2021, v. 6, n. 3, p. 132, doi. 10.1159/000515593

By:

Sagar, Rebecca;
Lenti, Marco V.;
Clark, Tanya;
Rafferty, Helen J.;
Gracie, David J.;
Ford, Alexander C.;
O'Connor, Anthony;
Ahmad, Tariq;
Hamlin, P. John;
Selinger, Christian P.

Publication type:

Article

6

High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients.

Published in:

Inflammatory Intestinal Diseases, 2021, v. 6, n. 3, p. 165, doi. 10.1159/000518264

By:

Sutter, Manuel;
Hruz, Petr;
Niess, Jan Hendrik

Publication type:

Article